person

Enrique E.

Country
Spain
Department
Oncología Médica

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
2
Sites with multiple studies

Has run more than one trial at 2 of 21 partner sites.

Specializations

Thoracic and solid tumour oncology

Clinical research activity includes advanced malignancies with a strong emphasis on non-small cell lung cancer, small cell lung cancer, breast cancer, gastrointestinal cancers, and urothelial carcinoma, alongside broader work in metastatic and biomarker-defined solid tumours.

  • NSCLC and SCLC
  • Breast cancer
  • Gastrointestinal malignancies
  • Urothelial carcinoma
  • Advanced solid tumours

Therapeutic interest extends to targeted therapies, immuno-oncology, and treatment strategies for metastatic disease.

Hematologic malignancies and cell therapy

The investigator is involved in studies spanning acute leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, and other blood and lymphatic diseases, with attention to both newly diagnosed and relapsed or refractory settings.

  • Acute lymphoblastic leukemia
  • Acute myeloid leukemia
  • Diffuse large B-cell lymphoma
  • Multiple myeloma
  • Myelodysplastic syndromes

Research activity also includes CAR T-cell therapy, bispecific immunotherapy, and other novel hematologic treatment approaches.

Autoimmune, inflammatory, and dermatologic diseases

Clinical interest covers immune-mediated disorders such as Crohn's disease, ulcerative colitis, psoriatic arthritis, axial spondyloarthritis, systemic lupus erythematosus, and atopic dermatitis, as well as inflammatory skin conditions including hidradenitis suppurativa and psoriasis.

  • Inflammatory bowel disease
  • Rheumatic disease
  • Atopic dermatitis
  • Psoriasis
  • Hidradenitis suppurativa

The therapeutic scope includes immune modulation, pruritus control, and other inflammatory pathway-directed interventions.

Cardiovascular, thrombotic, and metabolic disease

Research involvement also spans atrial fibrillation, heart failure, myocardial infarction, stroke, atherosclerotic cardiovascular disease, and thromboembolic disorders, together with obesity and metabolic dysfunction-associated steatohepatitis.

  • Atrial fibrillation
  • Heart failure
  • Myocardial infarction
  • Stroke prevention
  • Metabolic liver disease

Therapeutic focus includes cardiovascular risk reduction, antithrombotic therapy, and treatment strategies for cardiometabolic disease.

Rare disease, genetic, and infectious conditions

The investigator is active in studies of haemophilia, hereditary angioedema, spinal muscular atrophy, amyotrophic lateral sclerosis, myasthenia gravis, and selected pediatric and transplant-related disorders, alongside infectious diseases such as respiratory syncytial virus infection, COVID-19, and pneumococcal disease.

  • Haemophilia
  • Hereditary angioedema
  • Neuromuscular disease
  • Transplant-related complications
  • Respiratory infections

These areas reflect involvement in orphan disease care, immune deficiency, and infection prevention strategies.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.